Eurosilicone is a brand of silicone gel–filled breast implants manufactured in France and available in Europe, Asia, Australia, and South America. Although Eurosilicone implants are used in other parts of the world, they’re not approved for use in the U.S. They do, however, bear the CE mark, which is the equivalent of FDA approval in the European Union.
Eurosilicone implants come in round (aka the Round Collection) or anatomical shapes (aka the Matrix) in a variety of sizes, profiles, and densities, with 335 variations in all. They’re made with cohesive silicone, a type of gel that’s able to hold its shape, and include a barrier layer called Paragel that helps keeps the gel in place.
They’re available with either a smooth or textured surface known as Cristalline. The texture provides a grippier surface; to help hold the implant in place—but textured implants have been implicated in the development of a rare type of cancer of the immune system called breast implant–associated anaplastic large-cell lymphoma (BIA-ALCL). As a precautionary measure, some textured implants have been banned in a number of countries, including Australia, France, and Canada. (Smooth implants are not linked to BIA-ALCL.)
It’s important to keep in mind that Eurosilicone breast implants—like all breast implants—are not lifetime devices and may need to be removed, updated, or replaced if complications or issues like leaking, wrinkling, or migration occur as they age.
In a 2019 study that followed nearly 526 women who had Eurosilicone implants for 10 years, 74 women experienced capsular contracture (actual rate, 13.7%); 16 implants ruptured (actual rate, 3%); and there were 80 reported incidents of surgical re-intervention (explantation or implant exchange). According to the researchers, the findings demonstrate relatively low complication rates for these implants.
Learn more about all potential risks and complications of breast implants.
